Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-31
1991-09-03
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514293, 514885, A01N 4360, A61K 31495, A61K 3144
Patent
active
050455427
ABSTRACT:
A method and composition for suppressing the immune response are disclosed which employ an immunosuppressing effective amount of certain aryl-substituted naphthyridines and pyrido-pyrazines.
REFERENCES:
patent: 4492702 (1985-01-01), Sherlock
patent: 4596809 (1986-06-01), Sherlock
patent: 4632923 (1986-12-01), Blythin
patent: 4652564 (1987-03-01), Blythin
patent: 4666922 (1987-05-01), Smith et al.
patent: 4680298 (1987-07-01), Blythin
patent: 4684727 (1987-08-01), Blythin et al.
patent: 4760073 (1988-07-01), Blythin et al.
patent: 4801589 (1989-01-01), Smith et al.
patent: 4882332 (1989-11-01), Siegel et al.
Bulletin de la Societe Chimique de France, No. 1, 1968, pp. 364-369; C. Fournier, et al.
Derwent Abstract of Japanese Published Patent 58-144391 (8/83).
Stites et al., (eds) Basic & Clinical Immunology 5th ed. pp. 509-512 (Lange Medical Publications ) 1984.
Siegel Marvin I.
Smith Sidney R.
Azpuru Carlos
Nelson James R.
Page Thurman K.
Rosen Gerald S.
Schering Corporation
LandOfFree
Immune suppression method employing aryl-substituted naphthyridi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immune suppression method employing aryl-substituted naphthyridi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immune suppression method employing aryl-substituted naphthyridi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1009534